UnitedHealth Group $UNH reported solid adjusted earnings of $6.38 per share on a massive $112B in revenue, nudging its full-year guidance upward.
THE FORECAST: Backed by excellent Medicare performance, management lifted its full-year adjusted EPS guidance to a strong $19.50–$20.00 range.
THE HEADWINDS: Under the hood, commercial medical costs spiked over 11%. This stubborn trend is stretching the company's projected margin recovery timeline out past 2027.
THE REWARD: Shareholders are seeing a payout bump, with the annualized dividend hitting $9.28 alongside a planned $5B share buyback program.
THE RATING: Fading commercial cost efficiency balanced against high consumer demand keeps the Seeking Alpha Quant score locked at a neutral HOLD.
显示更多